Back to top

Taysha Gene Therapies falls -11.0%

Taysha Gene Therapies (TSHA) is down -11.0%, or -70c to $5.64. Published first on TheFly – the ultimate source for real-time, market-moving breakin...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Taysha Gene Therapies, Inc. (TSHA)